MoodSpark buys defunct startup’s IP, minds focused on disrupting elderly veterans’ depression
May 11, 2022 | Startland News Staff
A slew of new patents and tools are now in the hands of a KCK-rooted startup that aims to protect aging military veterans that suffer from loneliness, anxiety and depression.
MoodSpark has acquired assets previously held by California-based Dthera Sciences — an early leader of the digital therapeutics space, known for its innovative quality of life therapies, the company announced Wednesday.
MoodSpark’s digital companion uses artificial intelligence to detect such behaviors, alert family, friends, or caregivers, provide digital check ins and assistance in times of social isolation, provide behavioral health intervention, and share engagement data, activity, and response information with caregivers.
As part of the acquisition, MoodSpark has received a sizable IP portfolio that contains patents, a technology platform, an FDA breakthrough device designation, and clinical pilot research related to Dthera’s system for treating anxiety, agitation, and depression in elderly patients experiencing neurodegenerative diseases that include Alzheimers and dementia.
The publicly traded company ended operations in late 2019 after raising about $5 million in five years.
“Dthera pioneered digital therapeutics targeting geriatric CNS disorders. This deal provides us a significant amount of market validation, broadens our IP portfolio, and gets us closer to our dual-use vision for the MoodSpark digital companion,” said Eliot Arnold, co-founder of MoodSpark and a 2021 Techstars Kansas City cohort member.
The Dethera assets will be used in combination with existing MoodSpark technology — known for its ability to detect sadness and promote (or spark) a shift in a person’s mood using memories, conversations, and video visits from loved ones.
“Some of the brightest minds in digital therapeutics were behind Dthera. We are very excited to bring the combined solution to market and establish ourselves as a market leader in social assistive technology.”
Want to learn more about MoodSpark? Click here to further explore its technology.
As the company rolls its new IP into its existing growth strategy, MoodSpark intends to use its technology to reach aging U.S. veterans, the company said.
“The United States has the largest generation of warfighters quickly approaching or at retirement age,” the company explained, noting the Department of Veterans Affairs lists anxiety, depression, loneliness, and social isolation as on the rise among senior veterans.
“The United States is increasingly turning to advanced technology to not only support independent living among older veterans, but to foster human connections and combat cognitive decline.”
2022 Startups to Watch
stats here
Related Posts on Startland News
Pioneering KCI airport vote should help land top talent, startup leaders say
Capping a six-year journey fraught with turbulence, delays and political drama, voters overwhelmingly ratified plans to build a new $1.3 billion airport terminal, which would replace the existing Kansas City International Airport (KCI). “Kansas City has never been about being just mediocre,” said Michael Wilson, founder of luxury watch brand Niall and a frequent traveler…
WillCo Tech’s sale allows founder guilt-free $200K investment in smart grid startup
Selling a majority stake in his IT consulting firm will allow Kevin Williams to focus on and expand his startup venture, the Kansas City tech entrepreneur said. Although the exact amount was undisclosed, the acquisition by Ohio-based Metisentry earlier this month provided a big enough payoff to fund Williams’ and his wife’s future retirement, as…
After $2.95M round, corporate deal ensures word-of-mouth marketing for RiskGenius
RiskGenius’ $2.95 million series A extension funding round is worth more than its face value, said CEO Chris Cheatham. The round was led by QBE Ventures, an Australia-based firm known as being among the world’s top 20 insurance companies. In addition to the funds, QBE North America will be the first division to fully implement…
Likarda scaling up biotech research firm with $4M angel boost, new lab
An animal’s diabetes diagnosis comes with a heavy burden for the pet’s owners, Lisa Stehno-Bittel said. And it’s not just the cost of treatment, the president and co-founder of Likarda added. “Of those who will try twice-daily insulin injections, within a year, half of those have given up,” she said. “A lot of that is…